FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA has approved a supplemental application for EXFORGE, the fixed-dose combination of amlodipine besylate and valsartan, submitted by Novartis Pharmaceutic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

SUPPL AP for EXFORGE (AMLODIPINE BESYLATE AND VALSARTAN)